Would you give transdermal hormone replacement therapy to a woman with remote history of provoked pulmonary embolism?

There is good evidence that transdermal HRT does not pose the same risks as oral HRT (Morris and Talaulikar, PMID 36573625). ASA or DOAC prophylaxis is likely not indicated.